Literature DB >> 15920410

Development and validation of an age-risk score for mortality predication after thermal injury.

Aimee R Moreau1, Peter H Westfall, Leopoldo C Cancio, Arthur D Mason.   

Abstract

BACKGROUND: In burn patients, the risk of mortality typically decreases as children mature, reaches a nadir at age 21, rises linearly thereafter, and levels off in old age. We hypothesized that a single "age-risk score" (AGESCORE), incorporating a cubic functional form, can be used in predictive models for mortality after burns.
METHODS: Data from 6,395 thermally injured patients admitted to a single burn center between January 1, 1950, and December 31, 1999, were used. Variables included age, total burn size, year of discharge, and survival. AGESCORE was defined as follows: -5(age) + 14(age/100) -7(age/10,000). Logistic regression verified the cubic functional form of the age-mortality relationship. Models using a general cubic functional form of age, and AGESCORE, were compared for lack of fit. The stability of AGESCORE was assessed over six distinct treatment eras within the 50-year period. AGESCORE was also validated using data from a different burn center.
RESULTS: AGESCORE provided an accurate method for modeling mortality in burn patients across different age groups, burn sizes, eras, and burn centers.
CONCLUSION: The benefits of a standardized index of age risk include ease of comparison, reduction of bias, and increased efficiency attributable to statistical parsimony. The applicability of this approach to nonthermal trauma patients remains to be seen.

Entities:  

Mesh:

Year:  2005        PMID: 15920410     DOI: 10.1097/01.ta.0000162729.24548.00

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  7 in total

1.  Comparison between civilian burns and combat burns from Operation Iraqi Freedom and Operation Enduring Freedom.

Authors:  Steven E Wolf; David S Kauvar; Charles E Wade; Leopoldo C Cancio; Evan P Renz; Edward E Horvath; Christopher E White; Myung S Park; Sandra Wanek; Michael A Albrecht; Lorne H Blackbourne; David J Barillo; John B Holcomb
Journal:  Ann Surg       Date:  2006-06       Impact factor: 12.969

2.  Effects of burn injury on markers of hypermetabolism in rats.

Authors:  Maria-Louisa Izamis; Korkut Uygun; Basak Uygun; Martin L Yarmush; François Berthiaume
Journal:  J Burn Care Res       Date:  2009 Nov-Dec       Impact factor: 1.845

3.  Total intravenous anesthesia for major burn surgery.

Authors:  Leopoldo C Cancio; Phillip B Cuenca; Stephen C Walker; John M Shepherd
Journal:  Int J Burns Trauma       Date:  2013-04-18

4.  Fungal wound infection (not colonization) is independently associated with mortality in burn patients.

Authors:  Edward E Horvath; Clinton K Murray; George M Vaughan; Kevin K Chung; Duane R Hospenthal; Charles E Wade; John B Holcomb; Steven E Wolf; Arthur D Mason; Leopoldo C Cancio
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

5.  Hyperphosphatemia is associated with high mortality in severe burns.

Authors:  George Kuo; Cheng-Chia Lee; Shih-Yi Yang; Yen-Chang Hsiao; Shiow-Shuh Chuang; Su-Wei Chang; Kun-Hua Tu; Pei-Chun Fan; Ya-Chung Tian; Yung-Chang Chen; Chih-Hsiang Chang
Journal:  PLoS One       Date:  2018-01-09       Impact factor: 3.240

6.  Harborview burns--1974 to 2009.

Authors:  Loren H Engrav; David M Heimbach; Frederick P Rivara; Kathleen F Kerr; Turner Osler; Tam N Pham; Sam R Sharar; Peter C Esselman; Eileen M Bulger; Gretchen J Carrougher; Shari Honari; Nicole S Gibran
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

7.  Serum albumin level as a risk factor for mortality in burn patients.

Authors:  Olivia Alejandra Aguayo-Becerra; Carlos Torres-Garibay; Michel Dassaejv Macías-Amezcua; Clotilde Fuentes-Orozco; Mariana de Guadalupe Chávez-Tostado; Elizabeth Andalón-Dueñas; Arturo Espinosa Partida; Andrea Del Socorro Alvarez-Villaseñor; Ana Olivia Cortés-Flores; Alejandro González-Ojeda
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.